| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |